563 related articles for article (PubMed ID: 32705178)
1. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).
Chiangjong W; Chutipongtanate S; Hongeng S
Int J Oncol; 2020 Sep; 57(3):678-696. PubMed ID: 32705178
[TBL] [Abstract][Full Text] [Related]
2. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
3. Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
Alamdari-Palangi V; Jaberi KR; Shahverdi M; Naeimzadeh Y; Tajbakhsh A; Khajeh S; Razban V; Fallahi J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15249-15273. PubMed ID: 37581648
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Activities of Natural and Synthetic Peptides.
Hilchie AL; Hoskin DW; Power Coombs MR
Adv Exp Med Biol; 2019; 1117():131-147. PubMed ID: 30980357
[TBL] [Abstract][Full Text] [Related]
5. Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy.
Aronson MR; Simonson AW; Orchard LM; Llinás M; Medina SH
Acta Biomater; 2018 Oct; 80():269-277. PubMed ID: 30240951
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides.
Zhao Y; Wang S; Fei W; Feng Y; Shen L; Yang X; Wang M; Wu M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073203
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
[TBL] [Abstract][Full Text] [Related]
8. Anti-Cancer Peptides: Status and Future Prospects.
Ghaly G; Tallima H; Dabbish E; Badr ElDin N; Abd El-Rahman MK; Ibrahim MAA; Shoeib T
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770815
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Computational Methods for Identifying Anticancer Peptides.
Feng P; Wang Z
Curr Drug Targets; 2019; 20(5):481-487. PubMed ID: 30068270
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of anticancer peptides (ACPs) from amphibian origin.
Oelkrug C; Hartke M; Schubert A
Anticancer Res; 2015 Feb; 35(2):635-43. PubMed ID: 25667440
[TBL] [Abstract][Full Text] [Related]
11. DRACP: a novel method for identification of anticancer peptides.
Zhao T; Hu Y; Zang T
BMC Bioinformatics; 2020 Dec; 21(Suppl 16):559. PubMed ID: 33323099
[TBL] [Abstract][Full Text] [Related]
12. Peptides as therapeutics with enhanced bioactivity.
Goodwin D; Simerska P; Toth I
Curr Med Chem; 2012; 19(26):4451-61. PubMed ID: 22830348
[TBL] [Abstract][Full Text] [Related]
13. CAPTURE: Comprehensive anti-cancer peptide predictor with a unique amino acid sequence encoder.
Ghafoor H; Asim MN; Ibrahim MA; Ahmed S; Dengel A
Comput Biol Med; 2024 Jun; 176():108538. PubMed ID: 38759585
[TBL] [Abstract][Full Text] [Related]
14. Anticancer peptides mechanisms, simple and complex.
Norouzi P; Mirmohammadi M; Houshdar Tehrani MH
Chem Biol Interact; 2022 Dec; 368():110194. PubMed ID: 36195187
[TBL] [Abstract][Full Text] [Related]
15. Guidance for peptide vaccines for the treatment of cancer.
Yamaguchi Y; Yamaue H; Okusaka T; Okuno K; Suzuki H; Fujioka T; Otsu A; Ohashi Y; Shimazawa R; Nishio K; Furuse J; Minami H; Tsunoda T; Hayashi Y; Nakamura Y;
Cancer Sci; 2014 Jul; 105(7):924-31. PubMed ID: 25040224
[TBL] [Abstract][Full Text] [Related]
16. Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties.
Huang KY; Tseng YJ; Kao HJ; Chen CH; Yang HH; Weng SL
Sci Rep; 2021 Jun; 11(1):13594. PubMed ID: 34193950
[TBL] [Abstract][Full Text] [Related]
17. ACP-MHCNN: an accurate multi-headed deep-convolutional neural network to predict anticancer peptides.
Ahmed S; Muhammod R; Khan ZH; Adilina S; Sharma A; Shatabda S; Dehzangi A
Sci Rep; 2021 Dec; 11(1):23676. PubMed ID: 34880291
[TBL] [Abstract][Full Text] [Related]
18. On the selectivity and efficacy of defense peptides with respect to cancer cells.
Harris F; Dennison SR; Singh J; Phoenix DA
Med Res Rev; 2013 Jan; 33(1):190-234. PubMed ID: 21922503
[TBL] [Abstract][Full Text] [Related]
19. De novo design of anticancer peptides by ensemble artificial neural networks.
Grisoni F; Neuhaus CS; Hishinuma M; Gabernet G; Hiss JA; Kotera M; Schneider G
J Mol Model; 2019 Apr; 25(5):112. PubMed ID: 30953170
[TBL] [Abstract][Full Text] [Related]
20. Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer.
Bakare OO; Gokul A; Wu R; Niekerk LA; Klein A; Keyster M
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
